Female cancer survivors are experiencing neuropathy. For Life.
About half of female cancer survivors had persistent symptoms of chemotherapy-induced peripheral neuropathy (CIPN) for many years after treatment ended.
Chemotherapy-induced peripheral neuropathy is characterized by progressive, enduring, and is often an irreversible condition featuring pain, numbness, tingling and sensitivity to cold in the hands and feet sometimes with progression to the hands and feet.
CIPN symptoms are significant and potentially life-threatening for cancer survivors who are well beyond the completion of chemotherapy and close to the time that many will transition out of oncologic care.
Woman with CIPN reported a slower gait, the need to take shorter and more frequent steps and significantly more disability than women who were asymptomatic. A current study is calling for ways to manage mobility and balance deficits early, recommending balance, sensation and mobility assessments before and after chemotherapy.
Unfortunately, it is the treatment that causes peripheral neuropathy.
A fall due to CIPN can be catastrophic for a chemotherapy patient with low blood counts who sustains a fracture or head injury. Younger patients are at higher risks as they typically receive more aggressive treatments. The study found that patients with CIPN were also more likely to have stage II or III cancer other than breast cancer, be obese and/or less physically active or have worse comorbities.
It is often recommended that patients with neuropathy follow a healthy diet and manage blood sugar levels, exercise, reduce exposure to toxins/ quit smoking, manage stress and protect your skin.
We treat chemotherapy induced peripheral neuropathy with I.V. Ozone and alternate treatments of Alpha Lipoic Acid. We also recommend a standardized oral version of Alpha Lipoic Acid on the days when you are not getting an I.V. The peripheral neuropathy ususally resolves within 6-8 sessions.
I recommend Xymogen's ALAmax CR every day.
And definitely book your new patient consult and same day I.V. Ozone treatment.
You have already suffered enough with the diagnosis and treatment; don't continue to suffer with lifelong peripheral neuropathy from treatment.
Jenkins, K. (2017, June 16). Female Cancer Survivors Face Years of Neuropathy. Retrieved June, 2017, from https://www.medpagetoday.com/HematologyOncology/Chemotherapy/66086?xid=nl_mpt_DHE_2017-06-17&eun=g1124734d0r&pos=0